Recombinant Human CYLD

Product Specifications

Product Name Alternative

BRSS, CDMT, CYLD, CYLD1, CYLD1MFT, CYLDI, cylindromatosis (turban tumor syndrome), Deubiquitinating enzyme CYLD, EAC, EC 3.1.2.15, EC 3.4.19.12, FLJ20180, FLJ31664, KIAA0849FLJ78684, MFT1, probable ubiquitin carboxyl-terminal hydrolase CYLD

UniProt

Q9NQC7

Expression Region

1-226

Host

E.Coli

Tag

N-terminal His-IF2DI Tag

Applications

Western Blot, ELISA

Field of Research

Epigenetics, Immunology, Metabolism

Purity

Greater than 90% as determined by SDS-PAGE.

Form

Lyophilized powder

Reconstitution

Centrifuge the vial before opening, reconstitute in sterile distilled water to a concentration of 0.1-1 mg/ml by gently pipetting 2-3 times, don't vortex.

Molecular Weight

46 kDa

Shipping Conditions

4°C with ice bag

Storage Conditions

The lyophilized protein is stable at -20 °C for up to 1 year. For extended storage, it is recommended to further dilute in working aliquots after reconstitution. The protein solution is stable at ≤ -20 °C for 3 months, or 2-7 days at 2-8 °C under sterile conditions.Avoid repeated freeze/thaw cycle.